Related Experiment Videos
Cerebrovascular effect of calcium antagonists
1Laboratoire de Pharmacodynamie Générale et de Pharmacologie, Université Catholique de Louvain, Bruxelles, Belgique.
European Neurology
|January 1, 1990
Summary
Calcium antagonists like nimodipine and flunarizine effectively reduced depolarization-induced responses in rat brain microvessels. These findings confirm their activity and highlight specific binding sites for dihydropyridine calcium channel blockers.
Area of Science:
- Pharmacology
- Neuroscience
- Cardiovascular Research
Background:
- Calcium ions play a crucial role in regulating vascular tone.
- Microvessels in the brain are critical for regulating cerebral blood flow.
- Calcium antagonists are a class of drugs used to treat various cardiovascular conditions.
Purpose of the Study:
- To investigate the activity of calcium antagonists in rat brain microvessels.
- To determine the effect of depolarization on microvessel diameter and calcium influx.
- To identify the binding characteristics of dihydropyridine calcium antagonists in brain microvessels.
Main Methods:
- Isolation of rat brain microvessels (5-50 microns internal diameter).
- Assessment of lanthanum-resistant 45Ca influx and microvessel diameter changes.
- Inhibition studies using calcium antagonists nimodipine and flunarizine.
- Radioligand binding assays using 3H(+)PN200-110 to identify Ca channels.
Main Results:
- High KCl solution caused increased 45Ca influx and reduced microvessel diameter, indicating depolarization-induced responses.
- Nimodipine and flunarizine significantly inhibited both depolarization-induced calcium influx and vasoconstriction.
- Binding studies confirmed the presence of voltage-dependent, stereoselective binding sites for dihydropyridine calcium antagonists.
Conclusions:
- Calcium antagonists nimodipine and flunarizine demonstrate significant activity in regulating rat brain microvessel function.
- The study provides evidence for the role of voltage-dependent calcium channels in mediating microvascular responses in the brain.
- The findings support the therapeutic potential of dihydropyridine calcium antagonists in neurological and cerebrovascular conditions.